LIMPER-DRF: Immediate Mobilization Versus 2 Weeks Cast Immobilization After Distal Radius Fracture Treated With Volar Locking Plate

Sponsor
Tampere University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05150925
Collaborator
(none)
240
2
2
35.7
120
3.4

Study Details

Study Description

Brief Summary

The aim of this study is to analyze return to work and functional outcome at 2 months between 2 weeks casting and immediate mobilization following volar plating for a DRF.

Condition or Disease Intervention/Treatment Phase
  • Other: Cast treatment
  • Other: Immediate mobilization
  • Procedure: Volar plating
N/A

Detailed Description

This study is a prospective, randomized, controlled trial. The aim of this study will be to compare the early postoperative outcomes of the patients enrolled in the early mobilization with those patients in post-operative 2-week casting following volar plating for a DRF. Co-primary outcome in this study will be return to work and Patient-Rated Wrist Evaluation (PRWE) 2 months after the operation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
240 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Immediate Mobilization Versus 2 Weeks Cast Immobilization After Distal Radius Fracture Treated With Volar Locking Plate - a Study Protocol for a Prospective, Randomized, Controlled Trial
Actual Study Start Date :
Dec 10, 2021
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Immediate mobilization after distal radius fracture treated with volar locking plate

Other: Immediate mobilization
Immediate mobilization postoperatively without casting

Procedure: Volar plating
Volar plating of distal radius fracture

Active Comparator: 2 weeks cast immobilization after distal radius fracture treated with volar locking plate

Other: Cast treatment
Dorsal cast placed in OR

Procedure: Volar plating
Volar plating of distal radius fracture

Outcome Measures

Primary Outcome Measures

  1. Patient-rated wrist evaluation questionnaire [2 months]

    The PRWE is a 15-item questionnaire designed to measure wrist pain and disability in daily activities. It ranges from 100 (worst) to 0 (best). It consists of 2 subscales. Pain subscale contains 5 items. Function subscale contains total 10 items which are further divided into 2 sections: specific activities (having 6 items) and usual activities.

  2. Return to work [2 months]

    Patient is asked if he or she has returned to the previous work. If no patient is asked is he or she Still on sick leave, partial sick leave or returned to other work.

Secondary Outcome Measures

  1. Patient-rated wrist evaluation questionnaire [4 weeks]

    The PRWE is a 15-item questionnaire designed to measure wrist pain and disability in daily activities. It ranges from 100 (worst) to 0 (best). It consists of 2 subscales. Pain subscale contains 5 items. Function subscale contains total 10 items which are further divided into 2 sections: specific activities (having 6 items) and usual activities.

  2. Patient-rated wrist evaluation questionnaire [6 months]

    The PRWE is a 15-item questionnaire designed to measure wrist pain and disability in daily activities. It ranges from 100 (worst) to 0 (best). It consists of 2 subscales. Pain subscale contains 5 items. Function subscale contains total 10 items which are further divided into 2 sections: specific activities (having 6 items) and usual activities.

  3. Patient-rated wrist evaluation questionnaire [12 months]

    The PRWE is a 15-item questionnaire designed to measure wrist pain and disability in daily activities. It ranges from 100 (worst) to 0 (best). It consists of 2 subscales. Pain subscale contains 5 items. Function subscale contains total 10 items which are further divided into 2 sections: specific activities (having 6 items) and usual activities.

  4. Return to work [4 weeks]

    Patient is asked if he or she has returned to the previous work. If no patient is asked is he or she Still on sick leave, partial sick leave or returned to other work.

  5. Return to work [6 months]

    Patient is asked if he or she has returned to the previous work. If no patient is asked is he or she Still on sick leave, partial sick leave or returned to other work.

  6. Return to work [12 months]

    Patient is asked if he or she has returned to the previous work. If no patient is asked is he or she Still on sick leave, partial sick leave or returned to other work.

  7. Overall sick leave [12 months]

    Total number of days of work during the 1 year study period

  8. Complications [4 weeks]

    Any surgery related complication: wound dehiscence, deep infection, flexor tendon rupture, nerve injury, mechanical complications, nonunion, malunion, complex regional pain syndrome

  9. Complications [2 months]

    Any surgery related complication: wound dehiscence, deep infection, flexor tendon rupture, nerve injury, mechanical complications, nonunion, malunion, complex regional pain syndrome

  10. Complications [6 months]

    Any surgery related complication: wound dehiscence, deep infection, flexor tendon rupture, nerve injury, mechanical complications, nonunion, malunion, complex regional pain syndrome

  11. Complications [12 months]

    Any surgery related complication: wound dehiscence, deep infection, flexor tendon rupture, nerve injury, mechanical complications, nonunion, malunion, complex regional pain syndrome

  12. Self-perceived working ability [4 weeks]

    Patient is asked to rate his os her working ability using two scales: NRS from 0 (fully disabled) to 10 (best capability) and ordinally (fully capable, partially capable, fully disabled).

  13. Self-perceived working ability [2 months]

    Patient is asked to rate his os her working ability using two scales: NRS from 0 (fully disabled) to 10 (best capability) and ordinally (fully capable, partially capable, fully disabled).

  14. Self-perceived working ability [6 months]

    Patient is asked to rate his os her working ability using two scales: NRS from 0 (fully disabled) to 10 (best capability) and ordinally (fully capable, partially capable, fully disabled).

  15. Self-perceived working ability [12 months]

    Patient is asked to rate his os her working ability using two scales: NRS from 0 (fully disabled) to 10 (best capability) and ordinally (fully capable, partially capable, fully disabled).

  16. Visual analogue pain scale [4 weeks]

    Overall pain during last 7 days in a scale from 0 to 100 (worst)

  17. Visual analogue pain scale [2 months]

    Overall pain during last 7 days in a scale from 0 to 100 (worst)

  18. Visual analogue pain scale [6 months]

    Overall pain during last 7 days in a scale from 0 to 100 (worst)

  19. Visual analogue pain scale [12 months]

    Overall pain during last 7 days in a scale from 0 to 100 (worst)

Other Outcome Measures

  1. Patient activity [4 weeks]

    Patient activity measured with triaxial wrist accelerometer

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Intra- or extra articular DRF (Colles, Smith, Volar barton)

  • operative treatment justified

Exclusion Criteria:
  • Refusal to participate in the study

  • Open fracture with a severity greater than Gustilo grade 1

  • Patient aged less than 18 or over 65

  • Patient does not understand written or spoken guidance in local languages

  • Pathological fracture

  • Previous fracture in the same wrist or forearm in the last 10 years, that has led to impairment of function

  • Ipsilateral fracture in upper extremity

  • Associated fractures of the ulna (except fractures of the PSU)

  • Polytrauma

Contacts and Locations

Locations

Site City State Country Postal Code
1 Teemu Karjalainen Jyväskylä Finland
2 Laura Kärnä Tampere Finland

Sponsors and Collaborators

  • Tampere University Hospital

Investigators

  • Study Director: Aleksi Reito, Tampere University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aleksi Reito, Associate professor, Tampere University Hospital
ClinicalTrials.gov Identifier:
NCT05150925
Other Study ID Numbers:
  • R21111
First Posted:
Dec 9, 2021
Last Update Posted:
Jan 27, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Aleksi Reito, Associate professor, Tampere University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 27, 2022